SPONSORED CONTENT

Cyril Amarchand Mangaldas advises on bulk share sale in Syngene International by Biocon

October 10, 2022 23:50 IST | ANI Press Release
Tennis player James Blake
Cyril Amarchand Mangaldas

Mumbai (Maharashtra)/ New Delhi [India], October 10 (ANI/BusinessWire India): Cyril Amarchand Mangaldas advised Biocon Limited (Biocon), in relation to the sale of shares by Biocon Limited in Syngene International Limited (Syngene International), by way of a bulk trade on the stock exchanges, aggregating to Rs 1220.28 crores.

The Capital Market Practice of Cyril Amarchand Mangaldas advised Biocon for the transaction and assisted with, reviewing, and finalizing the transaction documents. The transaction team was led by Reuben Chacko, Partner; Janhavi Manohar, Partner; with support from Tanvi Kini, Senior Associate.

Other Parties and Advisors to the transaction included Spark Capital Advisors (India) Private Limited and Avendus Capital Private Limited (Broker and Advisor, respectively); Linklaters Singapore Pte (U.S. federal securities law counsel to Broker and Advisor).

The transaction was signed on September 05, 2022; and closing on September 08, 2022.

This story is provided by BusinessWire India. ANI will not be responsible in any way for the content of this article. (ANI/BusinessWire India)

DISCLAIMER


(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

 

Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .